PF-Atlas › Clinical Trials › NCT06821464
A Trial of HRS-9813 in Healthy Subjects
HRS-9813 · Phase 1
Registry ID
NCT06821464
Phase
Phase 1
Status
Recruiting
Drug / intervention
HRS-9813
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Start
2025-02-17
Enrollment
45
Locations
1
About this trial
The study is being conducted to evaluate the safety and pharmacokinetics of HRS-9813 after multiple oral administration in healthy subjects.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06821464 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.